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RESEARCH ARTICLE

Whole blood viscosity and red blood cell adhesion: Potential
biomarkers for targeted and curative therapies in sickle cell
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Abstract
Sickle cell disease (SCD) is a recessive genetic blood disorder exhibiting abnormal
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blood rheology. Polymerization of sickle hemoglobin, due to a point mutation in the
β-globin gene of hemoglobin, results in aberrantly adhesive and stiff red blood cells
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(RBCs). Hemolysis, abnormal RBC adhesion, and abnormal blood rheology together
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complications. Here, we describe a microfluidic assay combined with a micro particle
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impair endothelial health in people with SCD, which leads to cumulative systemic
image velocimetry technique for the integrated in vitro assessment of whole blood
viscosity (WBV) and RBC adhesion. We examined WBV and RBC adhesion to laminin
(LN) in microscale flow in whole blood samples from 53 individuals with no hemoglobinopathies (HbAA, N = 10), hemoglobin SC disease (HbSC, N = 14), or homozygous
SCD (HbSS, N = 29) with mean WBV of 4.50 cP, 4.08 cP, and 3.73 cP, respectively.
We found that WBV correlated with RBC count and hematocrit in subjects with
HbSC or HbSS. There was a significant inverse association between WBV and RBC
adhesion under both normoxic and physiologically hypoxic (SpO2 of 83%) tests, in
which lower WBV associated with higher RBC adhesion to LN in subjects with HbSS.
Low WBV has been found by others to associate with endothelial activation. Altered
WBV and abnormal RBC adhesion may synergistically contribute to the endothelial
damage and cumulative pathophysiology of SCD. These findings suggest that WBV
and RBC adhesion may serve as clinically relevant biomarkers and endpoints in
assessing emerging targeted and curative therapies in SCD.

1

|

I N T RO DU CT I O N

gene of hemoglobin. Sickle hemoglobin (HbS) polymerizes into long
and stiff chains within the red blood cell (RBC) under low-oxygen con-

Sickle cell disease (SCD) is one of the most common inherited diseases

ditions.3,4 As a result, HbS-containing RBCs (sickle RBCs) become

It is caused by a single-point mutation in the β-globin

abnormally stiff and adherent (impairing microcirculatory blood flow),

1,2

in the world.

and fragile (resulting in hemolysis). Microvascular occlusion causes
Erdem Kucukal and Yuncheng Man contributed equally to this study.

episodic and unpredictable vaso-occlusive events (VOE), pain, and
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cumulative vasculopathy, which are hallmarks of SCD.5 Although the

To overcome these limitations, a number of microfluidic-based tech-

molecular mechanism of SCD has been well established, the complex

niques for blood rheology assessment have been introduced.38-45

underpinnings of VOE and cumulative vasculopathy are less well

Majority of these methods are equipped with complex instrumenta-

understood.6,7

tion techniques, such as vibrational noise spectrum,46 cantilever

Abnormalities of intrinsic rheological properties of whole blood

deflection,47 or electrical resistance measurement.48 Other micro-

have been reported in patients with SCD and have been implicated in

fluidic models based on conventional lithographic techniques have

8-12

the underlying pathophysiology.

Whole blood viscosity (WBV) is

recently been implemented to measure blood viscosity in both

largely determined by the viscosity of plasma, hematocrit (HCT), RBC

normoxic and hypoxic conditions.26,38,41,49 Here, we describe a new

deformability, and RBC aggregation.

13-19

In SCD, all of these proper-

microfluidic system integrated with a micro particle image velocimetry

ties are altered, resulting in a cumulative change in rheological charac-

(PIV) technique for integrated in vitro assessment of whole blood rhe-

12

teristics of whole blood.

Plasma viscosity in SCD has been shown to

ology and red blood cell adhesion in a clinically useful manner.

be abnormally increased during VOE episodes, perhaps due to alter-

Although the distinct effects of plasma viscosity, impaired RBC

ations in cytokine profile and plasma protein concentration during cri-

deformability, and elevated plasma protein levels on WBV are well

ses.18 Increased levels of some plasma proteins in SCD (eg, fibrinogen)

established in literature, a more comprehensive approach that takes

may also cause a marked increase in RBC aggregation, and thus higher

into account all these factors in a patient-specific fashion is needed to

WBV at lower shear rates.20 It has been shown that non-Newtonian

better understand the role of WBV in the pathophysiology of SCD.

behavior of blood stems mainly from cell-protein interactions at a

Here, we quantitate WBV using pre-processing-free whole blood

interactions.15

samples, without adopting the “HCT-matching” techniques, allowing

Deformability of healthy RBCs is a crucial biophysical property, ensur-

patient-specific and clinically relevant WBV measurements. This study

ing adequate blood flow into the smallest capillaries, which can be

is unique in that we simultaneously report WBV and RBC adhesion

smaller than individual RBCs.21,22 It has been shown that extensive

levels, under normoxic and hypoxic conditions, of individuals with

RBC deformation at relatively high shear rates (>50 seconds−1) is

SCD and demonstrate associations with clinical variables. This inte-

responsible for the shear-thinning behavior of whole blood, in which

grated approach is pivotal, since both WBV and RBC adhesion are likely

apparent viscosity decreases with increasing shear rate until it reaches

dictated by a number of physiological parameters in SCD. This platform

a plateau.23-25 However, in SCD, HbS polymerization (sickling) under

has the potential to provide a more comprehensive evaluation of new

low-oxygen conditions profoundly impairs RBC deformability in a

and emerging therapeutic interventions in SCD, including treatments

HCT

below

0.30,

26

reversible fashion.

rather

than

from

cell-cell

Ongoing sickling and unsickling during cyclic

transitions from normoxia to hypoxia eventually result in the forma-

designed to improve red cell properties, such as targeted, hemoglobin
modifying, and stem cell or gene-based curative therapies.

tion of permanently stiffened RBCs in the circulation.27 Impaired RBC
deformability in these patients likely accounts for altered viscosity in
SCD. The HCT, or the volume fraction of RBCs to the volume of

2

METHODS

|

whole blood, is another major determinant of WBV.28,29 HCT has an
exponential impact on WBV depending on the shear rate and may

2.1

|

Blood sample acquisition

surpass the effect of other contributors, particularly in the microvasculature. Sickle cell anemia (SCA), in which the individual possesses

Whole blood samples from de-identified adult (≥18) healthy donors

two copies of the sickle hemoglobin (HbSS), is the most severe geno-

and subjects with SCD seen in the Adult Sickle Cell Clinic at Univer-

type of SCD and leads to accelerated hemolysis and thus lower

sity Hospitals Cleveland Medical Center (UHCMC, Cleveland Ohio)

HCT.30,31 It has been shown that samples from individuals with HbSS

were collected in vacutainers with EDTA (ethylenediaminetetraacetic

exhibited lower whole blood viscosity values compared to healthy

acid), based on an Institutional Review Board (IRB) approved protocol.

controls (HbAA) or people with hemoglobin-SC disease (HbSC).32-34

All collected samples were stored at 4°C, and the experiments were

Increased whole blood viscosity in HbSC is mainly attributed to

conducted within 24 hours of venipuncture. Clinical information, med-

increased HCT relative to HbSS and to RBCs that are densely packed

ical treatments and previous comorbidities, were obtained, including

33

Notably, a proliferative retinopathy has been

total hemoglobin level, red blood cell (RBC) count, white blood cell

reported to associate with increased whole blood viscosity in people

(WBC) count, platelet count, lactate dehydrogenase (LDH) levels,

with HbSC SCD, but not in HbSS.35

mean corpuscular volume (MCV), hematocrit (HCT), and hemoglobin

with hemoglobin.

The conventional viscometers for the analysis of non-Newtonian

phenotype (via high-performance liquid chromatography (HPLC) with

fluids, such as whole blood, fall into two categories: drag flow type

the Bio-Rad Variant II Instrument (Bio-Rad, Montreal, QC, Canada) at

(eg, rotational viscometers) or pressure driven flow type (eg, capillary

the Core Laboratory of UHCMC). Only subjects infected with HIV or

viscometers).36,37 Although these viscometers provide accurate and

hepatitis C were ineligible for this study. HCT was defined as the vol-

reliable results, they require large sample volumes, long processing

ume ratio of RBCs to the volume of whole blood and expressed as a

times, and technical expertise, limiting their utility, where rapid viscos-

decimal fraction in SI units (e.g., 0.50 HCT in decimal fraction is equiv-

ity measurements with low sample volumes may be necessary.

alent to 50% HCT as percentage).
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Fabrication of microfluidic assays

(Dow Corning, Midland, MI) was placed inside an impermeable tubing
(Cole-Parmer, Vernon Hills, IL), creating an annular space through

Fabrication of microfluidic chips was performed as previously

which a gas composed of 5% CO2 and 95% N2 was flowed. The blood

described.49-52 Briefly, a double-sided adhesive (DSA) polyester film

sample was then injected through the permeable tubing and allowed

was placed in between a top polymethyl methacrylate (PMMA) cover,

to become hypoxic due to the gas diffusion between the sample and

and a bottom glass microscope slide pre-coated with 3-aminopropyl

gas flowing inside the annular space, resulting in an SpO2 of 83%

triethoxysilane (APTES, Gold Seal Electron Microscopy Sciences,

when blood flow reached the inlet of the microchannel. We have

Hatfield, PA). The DSA film and PMMA top cover were laser

designed this system to induce a SpO2 level of 83% as it closely

micro-machined to define the microchannel walls as well as inlet and

mimics the physiologically relevant hypoxic conditions.26 Similar to

outlet ports. The assembled devices consisted of three identical

normoxic viscosity measurement, a 500 μL whole blood sample was

4 mm × 25 mm × 0.05 mm

loaded and perfused at 20 mBar, and a video of 600 frames was

(width × length × height). The height of the microchannels was cho-

acquired in the middle of the microchannel under normoxic conditions

sen to mimic the size scale of post-capillary venules, as it has been

after steady-state flow condition. Thereafter, the blood was still

shown that this part of the microvasculature plays a critical role in the

allowed to perfuse while the controlled (hypoxic) gas filled the outer

initiation and progression of VOE events.

tubing, and a video of 6000 frames was started at the same time in

microchannels

with

dimensions

of

the same field of view.

2.3 | Micro particle image velocimetry for
normoxic viscosity measurements

2.5

The assembled microfluidic channels were rinsed with 100% ethanol

Frames of the recorded videos were extracted using Adobe Photoshop

and PBS, and were equipped with silicon tubing that were fixed with

CS5. A total number of 250 pairs of images (500 frames) were cross

epoxy at the inlet and outlet connection ports. A Flow EZ microfluidic

correlated to obtain the velocity vector maps using a customized

flow control system (Part No: LU_FEZ_0345; Fluigent, Lowell, MA)

Matlab Code (PIVLab).53,54 Red blood cells were employed as the trac-

was used to regulate the flow pressure in the microfluidic channels.

ing particles that were visible through the optically clear microfluidic

The microchannels were connected to the input well by the inlet sili-

channels (made of PMMA and glass slide). The time interval between

cone tubing and male Luer connectors, and were mounted on the

each successive image was set to 100 ms, which was the frame-per-

stage of an inverted microscope (Olympus IX83) coupled with a

second rate of the CCD camera. The cross correlation procedure was

charge-coupled device (CCD) microscopy camera (EXi Blue EXI-BLU-

carried out within two passes, in which the size of the interrogation

R-F-M-14-C) to obtain high-resolution videos of the blood flow, fol-

areas was 256 × 256 pixels with 50% overlap during the first pass, and

lowing the experimental setting in Figure S1. For each measurement,

the information collected in this pass was utilized for the calculations

|

Quantification of mean flow velocities

a 500 μL whole blood sample was loaded in the input well and per-

during the second pass within smaller interrogation areas (128 × 128

fused at a constant pressure of 20 mBar, and two videos of

pixels). The velocity vector maps (250 in total) were then averaged to

500 frames were taken at 10 frames per second in two different loca-

obtain an average velocity vector map. Twenty percent of the interro-

tions along the channel length. Data acquisition began oneminute

gation area was cropped near the edges, and the rest of the mean vec-

after the initiation of flow to allow it to reach a steady state. To

tor map was again averaged to calculate the average flow velocity.

ensure that no significant RBC settling occurred during the experi-

Because we used a volume-illumination method, the average velocity

ments, we quantified the grayscale intensity of the images acquired

vectors contained information throughout the entire microchannel

for 50 seconds following the initial oneminute waiting period. The

depth. To confirm that this velocity would correspond to mean flow

image grayscale intensity has been shown to correlate with sample

velocity, we repeated these experiments using a constant displacement

HCT.50 Figure S2 illustrates that the grayscale intensity of the images

syringe pump and compared our PIV calculations against the theoretical

recorded sequentially for 50 seconds (representing the entire experi-

mean flow velocity, which is given by the formula below:

ment duration) remained nearly unchanged, indicating there was no
significant RBC settling in the reservoir.

2.4 | Micro particle image velocimetry for hypoxic
viscosity measurements

Q
V =
A

ð1Þ

Where V is the mean velocity along the microchannel depth, Q is
the volumetric flow rate, and A is the cross-sectional area of the
microchannel. As shown in Figure S3, our results indicate that the

To achieve a physiologically relevant oxygen tension in flowing blood,

mean velocity obtained by the PIV experiments through the entire

we coupled a micro-gas exchanger at the inlet of the microchannel as

fluid volume actually represented the mean flow velocity in the

previously described.26 Briefly, a medical grade gas-permeable tubing

microchannel.
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2.6

|

Clinical whole blood viscosity measurements

paired and paired data respectively. To compare three or more groups,
we performed Kruskal-Wallis test with Dunn's multiple comparison.

Whole blood samples from 19 subjects were sent to the clinical core

A P value below .05 was considered to indicate statistical significance.

laboratory at UHCMC for standard reference viscosity measurements

The data is reported as mean ± SD.

by a piston-style viscometer (Cambridge Viscosity, Boston, MA). The
clinical reference viscosity measurements were conducted using
whole blood samples upon request without any dilution or pre-

3

RE SU LT S

|

processing.

3.1
2.7 | RBC adhesion assays under normoxic
conditions

|

Mean flow velocity as a surrogate for WBV

Here, we used mean flow velocities obtained via micro-PIV as a surrogate for whole blood viscosity. To correlate the measured flow velocities with the sample viscosity, the viscosity of 19 blood samples were

The RBC adhesion assays were performed in microfluidic channels

measured via a commercially available piston-style viscometer.

that

protein,

Figure 1A shows that there existed an inverse logarithmic relationship

LN. Functionalization of microfluidic channels were carried out as we

between the sample viscosity and mean flow velocity in the micro-

have previously described in detail.26,49,50 In contrast to the viscosity

channel at a constant pressure of 20 mbar, which was within the

experiments, a constant displacement pump was utilized to provide a

physiological range. Thus, we utilized the logarithmic equation to infer

constant wall shear stress throughout the microchannels. The wall

the microfluidic whole blood viscosity of the sample from the mean

shear stress is related to the velocity gradient and can be defined as

flow velocity determined by micro PIV, which will be referred to as

the product of shear rate and dynamic viscosity at the wall surface.

whole blood viscosity (WBV) henceforth. Adhering to this methodol-

The assembled and functionalized microfluidic devices were attached

ogy, we first quantified the viscosity of blood samples from subjects

with an inlet tubing and placed on a motorized microscope stage

with no hemoglobinopathies (HbAA), with hemoglobin-SC disease

(Olympus IX83). Undiluted whole blood samples were loaded into

(HbSC), and with homozygous sickle cell disease (HbSS) by utilizing

1 mL syringes and a total volume of 15 μL of blood was injected into

the “HCT-matching” technique, in which the blood samples were ini-

the microchannels at a constant shear stress of 1 dyne/cm2 using a

tially centrifuged to separate RBCs from whole blood. Then, the iso-

syringe pump (New Era NE-300, Farmingdale, NY), followed by a wash

lated RBCs were mixed with plasma obtained from the same sample

step (1X PBS, 1% BSA w/v, 0.09% sodium azide w/v) at a shear stress

at a ratio of 1:1 yielding a fixed HCT of 0.50. During this procedure,

of 1 dyne/cm2, during which non-adherent cells were removed from

we strictly adhered to the hemorheological and laboratory techniques

the microchannel. The wall shear stress acting upon an adherent RBC

guidelines published in 2009.55 This approach allowed us to analyze

on the microchannel surface will force the RBC to detach above a cer-

the effect of RBCs and plasma on determining whole blood viscosity

tain threshold. Thereafter, a 32 mm × 32 mm interrogation area was

of a sample by eliminating any possible contribution from sample-to-

scanned at 20× via the Olympus Cell Sense live imaging software, and

sample HCT variation.

were

functionalized

with

a

subendothelium

the total number of adherent RBCs was manually quantified using
Photoshop CS5 (Adobe Inc., San Jose, CA).

3.2
2.8 | RBC adhesion assays under hypoxic
conditions

|

Effect of hematocrit matching on WBV

In line with previous findings, our results showed that viscosity of
HCT-matched HbSS samples was significantly greater compared to
HbAA samples (Figure 1B, 4.89 ± 0.41 cP vs 4.15 ± 0.07 cP, P < .05,

Whole blood samples were perfused into the LN-functionalized

Mann-Whitney U test), likely due to abnormal RBCs and pro-

microchannels with the micro-gas exchanger at 1 dyne/cm2, which

inflammatory plasma from subjects with HbSS. However, it is well

was followed by same washing, imaging, and quantifying as described

known that subjects with SCD suffer from chronic anemia and have

previously.

much lower HCT values compared to people with HbAA, which may
have a significant impact on their whole blood viscosity. Therefore,
we next tested the viscosity of blood samples from subjects with

2.9

|

Statistical analysis

HbAA, HbSC, and HbSS using undiluted and whole blood samples
without pre-processing. As shown in Figure 1C and 1D, the mean vis-

The statistical analyses were performed using Minitab 19 (Minitab

cosity level of HbAA samples was the highest (4.50 ± 0.32 cP), then

Inc., State College, PA). Statistical comparison between two groups

HbSC (4.08 ± 0.28 cP), while HbSS samples displayed the lowest

was conducted using the Student's t test or paired t test for non-

mean WBV (3.73 ± 0.57 cP), in contrast to the HCT-matched results
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F I G U R E 1 Quantification of whole blood viscosity (WBV) for normal and SCD samples. A, A total number of 19 blood samples were tested
using the microfluidic platform to acquire the mean flow velocities. The clinical WBVs of these samples were obtained via a standard piston type
commercially available viscometer. There was a logarithmic correlation between the mean flow velocity and measured WBV. B, The whole blood
samples were centrifuged to isolate RBCs, which were then mixed with subject's own plasma at a ratio of 1:1 to obtain a sample with 0.50 HCT
before the viscosity measurements using the microfluidic platform. The microfluidic whole blood viscosity values were obtained by measuring the
mean flow velocity first and converting that value to the clinical WBV using the correlation function in A. Samples from individuals with
hemoglobin-SC disease (HbSC) or homozygous (HbSS) SCD had significantly greater WBV than samples from normal (HbAA) subjects at the 0.50
HCT level. The images below the graph are representative snapshots of the flow field and demonstrate similar brightness levels, which are
indicative of same HCT. C, Viscosity was determined using unprocessed whole blood samples that maintained their specific HCT levels during the
course of the assay. The images below the graph are representative snapshots of the flow field for indicated blood sample types at different HCT
levels. Brightness of the images correlates with sample HCT level. D, Mean RBC counts, HCT, WBV are shown for HbAA, HbSC, and HbSS.
Subjects with HbSS had significantly lower mean HCT, RBC count, and WBV relative to subjects with HbSC. Typical reference ranges for RBC
Count and HCT are shown.82 The P values in B, and C, were calculated using Kruskal-Wallis non-parametric test with the Dunn's multiple
comparison analysis. N represents the number of subjects tested. Error bars represent standard deviation (SD) of the mean [Color figure can be
viewed at wileyonlinelibrary.com]
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F I G U R E 2 Association of
microfluidic WBV with
hematological parameters in
people with HbSS. A, WBV
moderately and positively
correlates with subject HCT level,
B, RBC count and C, total
hemoglobin level. PCC: Pearson
correlation coefficient and the P
value were based on a linear
regression analysis. Blood samples
from homozygous (HbSS) SCD
subjects were used in this analysis
[Color figure can be viewed at
wileyonlinelibrary.com]

(Figure 1B). We observed a significant heterogeneity within the HbSS

also not strongly linearly (Figure S5, HCT: PCC = 0.35, P = .02; RBC:

group, in which the difference between the lowest and highest data

PCC = 0.56, P = .001, one-way ANOVA). These results confirm that

points was almost 2-fold. Of note, HbAA samples typically had lower

our microfluidic assay provides similar results compared to a commer-

grayscale intensities when imaged under a phase-contrast microscope

cial viscometer with regards to the dependence of whole blood viscos-

compared to HbSC and HbSS samples, which is indicative of higher

ity on sample HCT and total RBC count. No other significant

HCT (Figure S4).

associations between WBV and clinical variables, including lactate
dehydrogenase (LDH), absolute reticulocyte counts, mean corpuscular
volume, HbS levels, and fetal hemoglobin (HbF) levels, were detected

3.3 | WBV is heterogeneous and correlates with
hematological parameters in subjects with SCD

in this modest-sized study population. However, subjects with a recent
transfusion history (<3 months) had a significantly higher WBV, compared to those with no recent transfusion (Figure S6A, 4.01 ± 0.7 cP vs

Viscosity of whole blood is determined by a number of factors includ-

3.56 ± 0.4 cP, P < .05, Student's t test). The subject population with a

ing HCT (the ratio of RBC volume to whole blood volume).15 Our

recent transfusion had significantly lower HbS levels (Figure S6B, 39.7

results show that both HCT and total RBC count associate with WBV,

± 6.5% vs 77.1 ± 13.3%, P < .001, Student's t test). No association was

although the relationships were not entirely linear, demonstrating the

observed between WBV and hydroxyurea treatment (data not shown).

likelihood of other possible contributors to WBV (Figure 2A, HCT:
PCC = 0.51, P < .01; Figure 2B, RBC count: PCC = 0.54, P < .01, oneway ANOVA). Further, subjects with a lower WBV tended to have sig-

3.4

|

WBV correlates inversely with RBC adhesion

nificantly higher total hemoglobin levels (Figure 2C, PCC = 0.45,
P = .001, one-way ANOVA) although all the subjects in the study pop-

We and others have previously described an association between dis-

ulation had lower than normal HCT levels (Figure 1D). These findings

ease severity and RBC adhesion in SCD.49,50,56-59 Since our current

collectively suggest that our microfluidic approach accounts for rheo-

results suggest a heterogeneous WBV profile among patients with

logical differences made by a number of determinants of WBV. Simi-

HbSS, we next sought to determine whether there was an association

larly, clinical measurements of WBV in people with homozygous or

between RBC adhesion to the sub-endothelial protein Laminin

heterozygous SCD, using the piston-style viscometer, also displayed a

(LN) and WBV.49,59 Laminin has been shown to mediate sickle RBC

significant association with subjects' RBC counts and HCT levels, albeit

(HbSS RBC) adhesion through the RBC membrane receptor BCAM-
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F I G U R E 3 In HbSS, microfluidic WBV associated with normoxic and hypoxic RBC adhesion to LN in vitro. A, Whole blood samples from
people with HbSS (N = 29) were first tested for WBV in our microfluidic assay. Adhesion of RBCs from the same samples to immobilized LN was
quantified in microfluidic channels under physiologic flow conditions (shear stress = 1dyne/cm2). There was an inverse correlation between
microfluidic WBV and number of adherent RBCs to LN. Higher WBV and lower WBV levels, which were measured via our microfluidic system,
were categorized based on a threshold WBV value of 4 cP (dashed line), which was the lowest WBV of the healthy study population (HbAA).
B, Subjects with a lower WBV (<4 cP) displayed greater RBC adhesion to LN compared to those with a higher WBV (>4 cP). C Viscosity of whole
blood samples from control subjects (HbAA, N = 3)) and subjects with homozygous SCD (HbSS, N = 10) were quantified under hypoxia. Whole
blood samples were first injected into the microchannels in normoxic conditions, and the measurements were taken for 30 seconds. Then, the
samples were exposed to hypoxia within the gas permeable inlet tubing so that they were hypoxic (SpO2 of 83%) before flowing into the
microchannel. Image acquisition was carried out 5 minutes after hypoxia induction for hypoxic viscosity measurements. TheWBV of control
samples did not significantly change when exposed to hypoxia while SCD samples became more viscous under hypoxic conditions. D, Hypoxic
WBV inversely correlated with hypoxic RBC adhesion to LN. The P values in B, and C, were based on the Student's t test and paired t test
respectively. Pearson's correlation coefficient (PCC) and P value in (D) were based on a linear regression analysis. Error bars represent standard
deviation (SD) of the mean [Color figure can be viewed at wileyonlinelibrary.com]

Lu.60,61 Therefore, it constitutes a physiologically relevant substrate in
assessing RBC adhesion in vitro. The adhesion experiments and WBV

3.5 | Hypoxia-induced WBV increase is subjectspecific and may influence RBC adhesion in SCD

measurements were conducted in parallel using microfluidic channels.
Because the lowest limit of WBV from tested HbAA samples was

Polymerization of sickle hemoglobin (HbS) in hypoxia leads to abnor-

approximately 4 cP, we categorized the SCD study population into

mal RBC biophysical properties such as increased adhesiveness and

two groups: a subnormal (lower) WBV group (<4 cP, N = 21) and nor-

impaired deformability.26,62 Therefore, a hypoxic environment may

mal (higher) WBV (>4 cP, N = 8) as shown in Figure 3A. Notably, sub-

increase sickle WBV in an individual patient, due to the impact of RBC

jects with a lower WBV displayed significantly greater RBC adhesion

deformability. On the other hand, the ratio of HbS to normal hemo-

to LN, compared to those with a higher WBV (Figure 3B, 957 ± 767

globin (HbA) may be heterogeneous among individuals with SCD, who

vs 452 ± 331, P < .05, Student's t test). Moreover, RBC adhesion to

are often transfused. Finally, contribution of RBC deformability to

LN strongly associated with subject LDH levels, and borderline so for

WBV may be significantly altered depending on the HCT level.21 We

absolute reticulocyte count (Figure S7A, P = .003, PCC = 0.53; Fig-

integrated a micro gas exchanger to our microfluidic system, as we

ure S7B, P = .07, PCC = 0.35, respectively).

have previously described,26 in order to probe the change in WBV as

10968652, 2020, 11, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/ajh.25933 by CASE WESTERN RESERVE UNIVERSITY, Wiley Online Library on [20/12/2022]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

1252

well as RBC adhesion to LN deriving from the change from normoxic
to hypoxic conditions. Because RBC settling in the reservoir could
affect the measured viscosities, we quantified grayscale intensity
changes of the images that were acquired for 5 minutes following
flow initiation. As illustrated in Figure S8, there was no significant
change of RBC settling during the entire experimental setup, reflected
by the absence of a grayscale intensity change. Of note, the grayscale
intensities in Figure S8 do not represent flow velocity, and we did
observe a significant reduction in mean flow velocity under hypoxia as
shown in Figure 3. The hypoxic viscosity results showed that WBV of
control blood samples (HbAA, N = 3) remained relatively unchanged,
while HbSS samples (N = 10) became more viscous under hypoxia as
shown in Figure 3C (P = .007, Student's t test). Interestingly, we
observed an inverse relationship between hypoxic WBV and RBC
adhesion to LN in hypoxia, similar to that seen under normoxic conditions (Figure 3D, PCC = -0.6, P = .03, one-way ANOVA). In other words,
RBCs from samples with a lower hypoxic WBV had an increased
propensity to adhere to LN under hypoxic conditions.

4

|

DISCUSSION

Abnormal RBC adhesion and changes in WBV are two independent
but inter-related factors that contribute to the endothelial dysfunction and vaso-occlusion which underlie SCD.7,63-65 In vitro systems
as well as microfluidic platforms have been developed to tease out
the effects of altered blood rheology in SCD pathophysiology. How-

F I G U R E 4 Summary of key findings and multiple factors that
affect endothelial health in SCD. Increased hemolysis in SCD is linked
to elevated heme levels, lower hematocrit, lower RBC count, and may
have differential effects on endothelial health under normoxic and
hypoxic conditions. Free heme is toxic to the endothelium and leads
to activation and abnormal RBC adhesion, while hypoxia can further
increase RBC adhesion due to hemoglobin polymerization. Lower
WBV in normoxia, as shown in this work, could lead to reduced
endothelial shear stress, which has been linked to endothelial
activation. This study also highlights that hypoxia acutely increases
WBV and RBC adhesion in subjects with HbSS, which could plausibly
contribute to local occlusion and ischemia [Color figure can be viewed
at wileyonlinelibrary.com]

ever, in most studies, the authors utilized a HCT matching approach,
through which RBCs from whole blood samples were initially sepa-

Hypoxia is a strong modulator of whole blood rheology,70 particu-

rated and then re-suspended either in a physiologic buffer, or in the

larly in SCD, as the biophysical properties of HbSS RBCs significantly

plasma itself at a fixed HCT level. Although this approach is useful

change under low oxygen conditions, which in turn alters both WBV

in highlighting the role that RBCs play in determining whole blood

and cellular adhesion.21,26,59,74 We found no meaningful change in

rheology, it does not account for the effects of plasma proteins

WBV between normoxic and hypoxic conditions in HbAA samples,

or HCT.

but HbSS samples became significantly more viscous in hypoxia (Fig-

In this study, we quantified the viscosity of preprocessing-free

ure 3C). This acute rise in WBV under hypoxia could result in a lower

whole blood samples from a clinically-diverse SCD patient population.

mean blood flow velocity, promoting RBC sickling, vaso-occlusion,

Our findings revealed that sample HCT played a pivotal role in WBV.

and local ischemia due to increased RBC passage time through the

Thus, SCD samples were significantly more viscous compared to

microvasculature. This could increase local hypoxia, leading to a fur-

HbAA samples when HCT levels were matched, while the viscosity of

ther rise in WBV and increased cellular interactions between RBCs

SCD samples was heterogeneous and much lower compared to the

and endothelial cells, slowing down the blood flow and contributing

HbAA group when pre-processing free whole blood samples were

to local occlusion and ischemia (Figure 4).

tested.

In this work, we integrated analyses of WBV and RBC adhesion.

Our results demonstrated that subjects with HbSS SCD had het-

We found an inverse association between RBC adhesion and WBV in

erogeneous WBV profiles, with normal or subnormal WBVs compared

subjects with HbSS. A lower WBV strongly associated with a lower

to controls (HbAA), which may result in distinct pathophysiological

HCT. Similarly, LDH levels and absolute reticulocyte counts were sig-

consequences. A subnormal WBV depresses endothelial shear stress,

nificantly higher in subjects with a higher RBC adhesion profile, as we

66

A lower endothelial shear stress,

reported previously.26,49,50 Based on these findings, we speculate that

has been established as a pro-inflammatory stimulus and associated

a hemolytic environment associates with RBC adhesion and also leads

with a risk for initiation and progression of coronary atherosclero-

to a lower WBV due to reduced HCT, which explains the inverse rela-

sis.67-69 Therefore, we postulate that chronic subnormal WBV, due to

tionship between RBC adhesion and WBV. Further, a hemolytic envi-

anemia, may impose additional burdens to cardiovascular health and

ronment has been reported to damage the endothelium,71,72 while a

disease, particularly for people with HbSS who already suffer from a

lower WBV and thus lower endothelial shear stress may mediate acti-

high degree of micro and macro-vascular complications.

vation and adhesive interactions between endothelial cells and blood

which maintains endothelial health.
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cells in vivo, since cellular adhesion is strongly governed by applied
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